Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders.

Siniscalco D, Schultz S, Brigida AL, Antonucci N.

Pharmaceuticals (Basel). 2018 Jun 4;11(2). pii: E56. doi: 10.3390/ph11020056. Review.

2.

In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets.

Granata S, Santoro G, Masola V, Tomei P, Sallustio F, Pontrelli P, Accetturo M, Antonucci N, Carratù P, Lupo A, Zaza G.

Int J Mol Sci. 2018 Apr 20;19(4). pii: E1250. doi: 10.3390/ijms19041250.

3.

Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations.

Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D.

Int J Mol Sci. 2017 Jul 3;18(7). pii: E1425. doi: 10.3390/ijms18071425. Review.

4.

Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease.

Fabris A, Bruschi M, Santucci L, Candiano G, Granata S, Dalla Gassa A, Antonucci N, Petretto A, Ghiggeri GM, Gambaro G, Lupo A, Zaza G.

Kidney Int. 2017 Feb;91(2):459-468. doi: 10.1016/j.kint.2016.09.035. Epub 2016 Dec 1.

PMID:
27914711
5.

The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy.

Berghella AM, Contasta I, Lattanzio R, Di Gregorio G, Campitelli I, Silvino M, Liberatore LL, Navarra L, Caterino G, Mongelli A, Vittorini V, Basta M, Domenicucci M, Antonucci N, Del Beato T, Secinaro E, Ciccone F, Pellegrini P.

Curr Drug Targets. 2017;18(4):485-495. doi: 10.2174/1389450117666160630173647.

PMID:
27397062
6.

Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder.

Siniscalco D, Mijatovic T, Bosmans E, Cirillo A, Kruzliak P, Lombardi VC, De Meirleir K, Antonucci N.

In Vivo. 2016 Mar-Apr;30(2):83-9.

PMID:
26912817
7.

Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases.

Antonucci N, Cirillo A, Siniscalco D.

Case Rep Psychiatry. 2015;2015:325061. doi: 10.1155/2015/325061. Epub 2015 Sep 29.

8.

Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study.

Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D.

Cell Transplant. 2014;23 Suppl 1:S105-12. doi: 10.3727/096368914X684916. Epub 2014 Oct 9.

PMID:
25302490
9.

Mesenchymal stem cells in treating autism: Novel insights.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

World J Stem Cells. 2014 Apr 26;6(2):173-8. doi: 10.4252/wjsc.v6.i2.173. Review.

10.

The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages.

Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N.

J Neuroinflammation. 2014 Apr 17;11:78. doi: 10.1186/1742-2094-11-78.

11.

Perspectives on the use of stem cells for autism treatment.

Siniscalco D, Bradstreet JJ, Sych N, Antonucci N.

Stem Cells Int. 2013;2013:262438. doi: 10.1155/2013/262438. Epub 2013 Oct 10. Review.

12.

Involvement of dietary bioactive proteins and peptides in autism spectrum disorders.

Siniscalco D, Antonucci N.

Curr Protein Pept Sci. 2013 Dec;14(8):674-9. Review.

PMID:
24106964
13.

Epigenetic findings in autism: new perspectives for therapy.

Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N.

Int J Environ Res Public Health. 2013 Sep 11;10(9):4261-73. doi: 10.3390/ijerph10094261. Review.

14.

Therapeutic role of hematopoietic stem cells in autism spectrum disorder-related inflammation.

Siniscalco D, Bradstreet JJ, Antonucci N.

Front Immunol. 2013 Jun 10;4:140. doi: 10.3389/fimmu.2013.00140. eCollection 2013.

15.

Possible use of Trichuris suis ova in autism spectrum disorders therapy.

Siniscalco D, Antonucci N.

Med Hypotheses. 2013 Jul;81(1):1-4. doi: 10.1016/j.mehy.2013.03.024. Epub 2013 Apr 15. Review.

PMID:
23597946
16.

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N.

J Autism Dev Disord. 2013 Nov;43(11):2686-95. doi: 10.1007/s10803-013-1824-9.

PMID:
23585028
17.

A novel in vitro sperm head decondensation protocol for rapid flow cytometric measurement of deoxyribonucleic acid content.

Antonucci N, Manes S, Corradetti B, Manicardi GC, Borini A, Bizzaro D.

Fertil Steril. 2013 Jun;99(7):1857-61. doi: 10.1016/j.fertnstert.2013.02.014. Epub 2013 Mar 15.

PMID:
23498889
18.

Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?

Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N.

J Biomed Biotechnol. 2012;2012:480289. doi: 10.1155/2012/480289. Epub 2012 Feb 13. Review.

19.

The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients.

Siniscalco D, Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, Fasano A, Maione S, Antonucci N.

J Autism Dev Disord. 2012 Jul;42(7):1403-10. doi: 10.1007/s10803-011-1373-z.

PMID:
21969075
20.

Genome size, GC percentage and 5mC level in the Indonesian coelacanth Latimeria menadoensis.

Makapedua DM, Barucca M, Forconi M, Antonucci N, Bizzaro D, Amici A, Carradori MR, Olmo E, Canapa A.

Mar Genomics. 2011 Sep;4(3):167-72. doi: 10.1016/j.margen.2011.04.001. Epub 2011 Jul 8.

PMID:
21867968

Supplemental Content

Loading ...
Support Center